Lidocaine via a feeding tube to prevent nausea after bariatric surgery
Official title: Effect of Lidocaine Applied Via Nasogastric Tube on Postoperative Nausea and Vomiting in Obese Patients Undergoing Bariatric Surgery
Run by General Hospital of Ningxia Medical University · NCT07643298 · Data updated 2026-11-12
This trial tests whether giving lidocaine through a stomach tube at the end of laparoscopic sleeve gastrectomy reduces nausea and vomiting in adults with obesity.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | General Hospital of Ningxia Medical University Academic / other |
| Locations | 1 site (Yinchuan, Ningxia) |
| Status | Recruiting |
| Started | May 20, 2026 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | June 11, 2026 |
| Trial ID | NCT07643298 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18-65 with ASA II-III scheduled for primary elective laparoscopic sleeve gastrectomy and able to consent.
✕Probably not a fit
Patients who do not respond to lidocaine exposure or who have contraindications may not experience a reduction in PONV.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults aged 18-65 undergoing primary laparoscopic sleeve gastrectomy are randomly assigned to receive either 0.5% lidocaine (20 ml) or normal saline (20 ml) through an orogastric tube after surgery and before extubation. The gastric tube is clamped for 5 minutes to allow mucosal exposure, and patients receive standardized anesthesia and perioperative care. PONV will be tracked in the post-anesthesia care unit and for the first 24 hours postoperatively to determine if lidocaine lowers incidence. The study builds on evidence of lidocaine’s anti-inflammatory and analgesic effects that may influence GI function and vomiting pathways. Overall, the trial examines a simple, inexpensive intervention to reduce a common bariatric complication.
Why it matters
Potential benefit: If successful, patients may experience fewer episodes of postoperative nausea and vomiting and a smoother early recovery.
How similar studies have gone: Previous perioperative lidocaine findings suggest potential GI benefits, but this specific intragastric approach for PONV prevention is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged between 18 and 65 years old; * American Society of Anesthesiologists (ASA) physical status classification II - III; * Planned to undergo primary elective laparoscopic sleeve gastrectomy with general anesthesia; * Capable of giving informed consent. Exclusion Criteria: * Known allergy, hypersensitivity or contraindication to lidocaine or amide - type local anesthetics; * Previous significant liver or kidney dysfunction (e.g., ALT/AST \> 3 times the upper limit of normal, GFR \< 30 mL/min); * History of epilepsy, cardiac conduction abnormalities or previous diagnosis of malignant hyperthermia; * Pregnancy or lactation; * Patients who received systemic lidocaine treatment during the operation; * History of severe postoperative nausea and vomiting (PONV) or motion sickness, requiring multiple prophylactic medications; * Emergency or revision bariatric surgery.
Where it's running
-
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, China Recruiting
Study contacts
- Study coordinator: Siying He
- Email: 1342850868@qq.com
- Phone: +86 18209610221
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Electroacupuncture plus dolasetron to prevent nausea and vomiting after thoracoscopic lung surgery
This trial will test whether adding electroacupuncture to standard anti-nausea medicines (dolasetron and dexamethasone) reduces postoperative nausea and vomiting in high-risk adults undergoing video-assisted thoracoscopic lung surgery.
-
Oliceridine vs Sufentanil for postoperative nausea after CPA surgery
This trial tests whether using oliceridine for patient-controlled IV pain relief reduces nausea after cerebellopontine angle surgery compared with sufentanil.
-
Dual-chamber patient-controlled pain relief after laparoscopic sleeve gastrectomy
This test checks whether a dual-chamber IV patient-controlled pump delivering fentanyl plus ketorolac reduces pain and postoperative nausea and vomiting in adults having laparoscopic sleeve gastrectomy.
-
Investigating pain and nausea after gallbladder surgery
This study looks at how common pain and nausea are after gallbladder surgery to see what factors might make these problems worse for patients.
-
Using electroacupuncture to reduce nausea after spinal surgery
This study is testing if a special type of acupuncture can help reduce nausea and vomiting after spinal surgery for patients.
-
Opioid-Free Anesthesia in FESS with ERAS
This study tries a opioid-free anesthesia approach during functional endoscopic sinus surgery to see if pain, nausea, and recovery are improved for adults undergoing this procedure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.